Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
32.53
+0.72 (2.26%)
Jun 10, 2026, 9:41 AM EDT - Market open

Vera Therapeutics Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$100
BuyMaintains$100+207.41%Jun 5, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$110
BuyMaintains$110+238.15%Jun 5, 2026
Goldman Sachs
Goldman Sachs
Buy
Maintains
$90
BuyMaintains$90+176.67%Jun 3, 2026
Wolfe Research
Wolfe Research
Buy
Maintains
$88
BuyMaintains$88+170.52%Jun 3, 2026
Guggenheim
Guggenheim
Buy
Reiterates
$56
BuyReiterates$56+72.15%Jun 3, 2026
Raymond James
Raymond James
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 2, 2026
LifeSci Capital
LifeSci Capital
Buy
Maintains
$90
BuyMaintains$90+176.67%Jun 2, 2026
TD Cowen
TD Cowen
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 2, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.